In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Discovery
Communications, Inc. (NASDAQ:DISCK), Otonomy, Inc. (NASDAQ:OTIC),
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Citizens Financial
Group, Inc. (NYSE:CFG), Washington Prime Group Inc. (NYSE:WPG), and
The Charles Schwab Corporation (NYSE:SCHW), including updated
fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
DISCK DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DISCK
OTIC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=OTIC
MRNS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=MRNS
CFG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CFG
WPG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=WPG
SCHW DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SCHW
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Discovery Communications, Inc. (NASDAQ:DISCK), Otonomy, Inc.
(NASDAQ:OTIC), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS),
Citizens Financial Group, Inc. (NYSE:CFG), Washington Prime Group
Inc. (NYSE:WPG), and The Charles Schwab Corporation (NYSE:SCHW) on
a fundamental level and outlines the overall demand for their
products and services in addition to an in-depth review of the
business strategy, management discussion, and overall direction
going forward. Several excerpts from the recently released reports
are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are
not designed to be standalone summaries and as such, important
information may be missing from these samples. All information in
this release was accessed November 15th, 2017. Please download the
entire research report, free of charge, to ensure you are reading
all relevant material information. All amounts in millions (except
per share amounts).
-----------------------------------------
Discovery Communications, Inc. (DISCK) REPORT
OVERVIEW
Discovery Communications' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Discovery Communications reported revenue
of $1,651.00 vs $1,556.00 (up 6.11%) and diluted earnings per share
$0.38 vs $0.36 (up 5.56%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, Discovery Communications
reported revenue of $6,497.00 vs $6,394.00 (up 1.61%) and diluted
earnings per share $1.96 vs $1.58 (up 24.05%). Discovery
Communications is expected to report earnings on February 13th,
2018. The report will be for the fiscal period ending December
31st, 2017. The reported EPS for the same quarter last year was
$0.56. The estimated EPS forecast for the next fiscal year is $2.30
and is expected to report on February 13th, 2018.
To read the full Discovery Communications, Inc. (DISCK) report,
download it here:
http://Fundamental-Markets.com/register/?so=DISCK
-----------------------------------------
Otonomy, Inc. (OTIC) REPORT OVERVIEW
Otonomy's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Otonomy reported revenue of $0.28 vs $0.32
(down 12.15%) and diluted earnings per share -$0.69 vs -$0.91. For
the twelve months ended December 31st, 2016 vs December 31st, 2015,
Otonomy reported revenue of $0.68 vs $0.00 and diluted earnings per
share -$3.69 vs -$2.57. Otonomy is expected to report earnings on
March 1st, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was -$0.88. The estimated EPS forecast for the next fiscal
year is -$2.31 and is expected to report on March 1st, 2018.
To read the full Otonomy, Inc. (OTIC) report, download it here:
http://Fundamental-Markets.com/register/?so=OTIC
-----------------------------------------
Marinus Pharmaceuticals, Inc. (MRNS) REPORT
OVERVIEW
Marinus Pharmaceuticals' Recent Financial
Performance
Marinus Pharmaceuticals is expected to report
earnings on March 12th, 2018. The report will be for the fiscal
period ending December 31st, 2017.
To read the full Marinus Pharmaceuticals, Inc. (MRNS) report,
download it here:
http://Fundamental-Markets.com/register/?so=MRNS
-----------------------------------------
Citizens Financial Group, Inc. (CFG) REPORT
OVERVIEW
Citizens Financial Group's Recent Financial
Performance
Citizens Financial Group is expected to report
earnings on January 19th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.55. The estimated EPS forecast for the
next fiscal year is $2.79 and is expected to report on January
19th, 2018.
To read the full Citizens Financial Group, Inc. (CFG) report,
download it here:
http://Fundamental-Markets.com/register/?so=CFG
-----------------------------------------
Washington Prime Group Inc. (WPG) REPORT
OVERVIEW
Washington Prime Group's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Washington Prime Group reported revenue of
$179.32 vs $209.92 (down 14.58%) and diluted earnings per share
-$0.06 vs $0.01. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Washington Prime Group reported revenue of
$843.48 vs $921.36 (down 8.45%) and diluted earnings per share
$0.29 vs -$0.55. Washington Prime Group is expected to report
earnings on February 28th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.48. The estimated EPS forecast for the
next fiscal year is $1.59 and is expected to report on February
28th, 2018.
To read the full Washington Prime Group Inc. (WPG) report,
download it here:
http://Fundamental-Markets.com/register/?so=WPG
-----------------------------------------
The Charles Schwab Corporation (SCHW) REPORT
OVERVIEW
Charles Schwab's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Charles Schwab reported revenue of
$2,165.00 vs $1,914.00 (up 13.11%) and diluted earnings per share
$0.42 vs $0.35 (up 20%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, Charles Schwab reported revenue of
$7,478.00 vs $6,380.00 (up 17.21%) and diluted earnings per share
$1.31 vs $1.03 (up 27.18%). Charles Schwab is expected to report
earnings on January 17th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.36. The estimated EPS forecast for the
next fiscal year is $1.95 and is expected to report on January
17th, 2018.
To read the full The Charles Schwab Corporation (SCHW) report,
download it here:
http://Fundamental-Markets.com/register/?so=SCHW
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Sep 2023 to Sep 2024